Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Forced Transdifferentiation01:28

Forced Transdifferentiation

2.0K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMT and cancer: what clinicians should know.

Nature reviews. Clinical oncology·2025
Same author

Glutamine modulates stress granule formation in cancer cells through core RNA-binding proteins.

Journal of cell science·2025
Same author

Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids.

Frontiers in oncology·2024
Same author

CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.

Brain : a journal of neurology·2024
Same author

Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.

Cells·2024
Same author

Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy.

Melanoma research·2024

Related Experiment Video

Updated: Aug 30, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.4K

Engaging plasticity: Differentiation therapy in solid tumors.

Neta Bar-Hai1,2, Dana Ishay-Ronen1,2

  • 1Cancer Research Center, Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Frontiers in Pharmacology
|August 29, 2022
PubMed
Summary

Cancer cell plasticity, including epithelial-mesenchymal transition (EMT), fuels tumor heterogeneity and treatment resistance. This review explores targeting cell plasticity for novel cancer therapies, particularly differentiation therapy.

Keywords:
EMTTGFb signalingcancer cell plasticitydifferentiation therapysolid tumorstrans-differentiation

More Related Videos

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.3K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K

Related Experiment Videos

Last Updated: Aug 30, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.4K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.3K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K

Area of Science:

  • Oncology
  • Cancer Biology
  • Cellular Plasticity

Background:

  • Cancer is a complex, heterogeneous disease characterized by periods of latency and activation.
  • Tumor progression involves increasing diversity, microenvironment adaptation, and therapeutic escape, necessitating cellular plasticity.
  • Epithelial-mesenchymal transition (EMT) is a key driver of cell plasticity, promoting dedifferentiation and cell type transitions in solid tumors.

Purpose of the Study:

  • To review the role of cancer cell plasticity in tumor progression and treatment challenges.
  • To explore therapeutic strategies aimed at overcoming dynamic processes driven by cell plasticity.
  • To discuss the potential of differentiation therapy by leveraging enhanced cell plasticity.

Main Methods:

  • Literature review focusing on cancer cell plasticity and therapeutic interventions.
  • Analysis of the mechanisms underlying epithelial-mesenchymal transition (EMT) and its contribution to tumor heterogeneity.
  • Exploration of treatment modalities targeting dynamic cancer cell processes.

Main Results:

  • Cancer cell plasticity, particularly EMT, significantly enhances tumor heterogeneity and poses a challenge to effective cancer treatment.
  • Dynamic processes like dedifferentiation and cell type transitions are critical for tumor adaptation and survival.
  • Existing therapeutic strategies often struggle to address the adaptability conferred by cell plasticity.

Conclusions:

  • Understanding and targeting cancer cell plasticity is crucial for developing more effective cancer treatments.
  • Therapeutic strategies must account for the dynamic and adaptive nature of cancer cells.
  • Differentiation therapy presents a promising approach by harnessing enhanced cell plasticity to restore tumor cell function.